New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody

Details for Australian Patent Application No. 2010302247 (hide)

Owner Sanofi

Inventors Bouchard, Herve; Commercon, Alain; Fromond, Claudia; Mikol, Vincent; Parker, Fabienne; Sassoon, Ingrid; Tavares, Daniel

Agent Watermark

Pub. Number AU-A-2010302247

PCT Pub. Number WO2011/039721

Priority 09305939.2 02.10.09 EP

Filing date 30 September 2010

Wipo publication date 7 April 2011

International Classifications

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/039721 Priority application(s): WO2011/039721

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302250-Antibodies that specifically bind to the EphA2 receptor

2010302245-Methods and apparatus to proxy discovery and negotiations between network entities to establish peer-to-peer communications